BJL
IMNM icon

Brighton Jones LLC’s Immunome IMNM Stock Holding History

Brighton Jones LLC’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$231K Buy
+10,573
New +$235K 0.01% 1029
2025
Q4 		– Sell
-10,513
Closed -$123K – 480
2025
Q3 		$123K Buy
10,513
+22
+0.2% +$219 ﹤0.01% 985
2025
Q2 		$97.6K Buy
+10,491
New +$86K ﹤0.01% 890
2024
Q2 		– Sell
-8,477
Closed -$209K – 652
2024
Q1 		$209K Buy
+8,477
New +$172K 0.01% 565

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Brighton Jones LLC's IMNM Position: Q1 2026 in Review

Brighton Jones LLC opened a new position in Immunome (IMNM) in Q1 2026: 10,573 shares worth $231K. The stake represents 0.01% of the portfolio and ranks #1029 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in IMNM as recently as Q3 2025.

Brighton Jones LLC first reported a position in IMNM in Q1 2024 and has held it in 4 quarters since. 201 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Brighton Jones LLC held 10,573 shares of Immunome worth $231K as of Q1 2026.
  • Immunome was a new Brighton Jones LLC position in Q1 2026.
  • Immunome made up 0.01% of Brighton Jones LLC's portfolio in Q1 2026, its #1029 holding.
  • Brighton Jones LLC first reported a position in Immunome in Q1 2024 and has held it in 4 quarters since.
  • 201 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.